The following search algorithm was applied: ((GLP-1 receptor agonist OR glucagon-like peptide-1 receptor agonist OR GIP receptor agonist OR glucose-dependent insulinotropic polypeptide OR liraglutide OR semaglutide OR dulaglutide OR tirzepatide) AND (body composition OR fat mass OR muscle mass OR lean mass OR adiposity OR body fat OR sarcopenia)) AND (clinical trial OR study OR randomized controlled trial OR RCT OR intervention study)
GLP-1s & other reward-driven behaviors The brain circuit identified in this study is involved in reward processing, a system that influences not only eating behavior but also other reward-driven behaviors
Do not adjust the dose amount
A quick recap: how GLP-1 medications work GLP-1 receptor agonists mimic a natural hormone called glucagon-like peptide-1, which is released in the gut after eating
Beyond primary care, the growth of digital and remote prescribing channels has broadened access to GLP-1 therapies significantly, reaching patients who may not easily access specialist weight management services through traditional routes
The co-occurrence of symptoms was examined through a cluster analysis, which mapped connections between side effects frequently mentioned together, helping to identify common symptom groupings
